Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 March, 2018 00:07 IST
Zydus Cadila gets USFDA's final nod for Tizanidine tablets
Source: IRIS | 13 Mar, 2018, 11.05AM
Comments  |  Post Comment

Zydus Cadila has received the final approval from the USFDA to market Tizanidine Tablets USP in the strengths of 2 mg and 4 mg.

The drug is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury and works by helping to relax the muscles.

It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

The group now has more than 180 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

Shares of the company gained Rs 11.3, or 2.94%, to trade at  Rs 395.10.  The total volume of shares traded  was  24,840 at the BSE (10.47 a.m., Tuesday).

Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Company Update
Ashok Leyland bags orders for 2,100 buses from Tamil Nadu - 21-Mar-2018 10:17
Suzlon designs and produces India's longest wind turbine blade - 21-Mar-2018 10:11
Mphasis partners with Plug and Play - 21-Mar-2018 09:55
Force Motors signs JV agreement with MTU Friedrichshafen GmbH - 21-Mar-2018 09:48
TCS partners with Saudi Real Estate Refinance Co - 21-Mar-2018 09:44
GE Power India secures contract worth Rs 3.09 bn - 21-Mar-2018 09:40
Alembic Pharm intimates of USFDA inspection of facility at Panelav - 21-Mar-2018 09:37
Mahindra & Mahindra partners with Standard Chartered - 20-Mar-2018 12:36
BHEL commissions 1st unit of Kishanganga hydro-electric project - 20-Mar-2018 10:12
Suzlon wins two projects of 300 MW and 200 MW each under SECI bid - 20-Mar-2018 10:08
Granules India receives approval for Metformin ER tablets - 20-Mar-2018 10:05
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer